Výsledky vyhledávání - "Hisanaga Nomura"

Akademický článek

Community pharmacists’ measurement of health-related quality of life for breast cancer with positive hormone receptors: A prospective observational study

Autor: Takenori Ichimura, Hisanaga Nomura, Hisanori Shimizu

Publikováno v: SAGE Open Medicine, Vol 11 (2023)

Objectives: Many patients with hormone-receptor positive breast cancer undergo prolonged treatment. However, the long-term patient quality of life assessment has not been examined. Using community pharmacists’ assistance is one method for assessing

Externí odkaz: https://doaj.org/article/0b2a27f2905e4ed9a05222c97fa92fad

Zobrazit plný text záznamu

Akademický článek

Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital

Autor: Koichi Matsuo, Hisanaga Nomura, Masanobu Uchiyama, Motoyasu Miyazaki, Osamu Imakyure

Publikováno v: BMC Health Services Research, Vol 20, Iss 1, Pp 1-7 (2020)

Abstract Background The substantial increase in the use of expensive anticancer drugs has been accompanied by an increase in the amount of disposing residual liquid from drug preparations. Many Western countries, including the United States, have imp

Externí odkaz: https://doaj.org/article/96f1b9ca53314ef9a76c0dc7ea350b7c

Zobrazit plný text záznamu

Akademický článek

Salient features and outline of the joint Japanese guidelines for safe handling of cancer chemotherapy drugs

Autor: Kiyoko Kanda, Kazue Hirai, Keiko Iino, Hisanaga Nomura, Hisateru Yasui, Taro Kano, Chisato Ichikawa, Sumiko Hiura, Tomoko Morita, Ayako Mitsuma, Hiroko Komatsu

Publikováno v: Asia-Pacific Journal of Oncology Nursing, Vol 4, Iss 4, Pp 304-312 (2017)

The purpose of this paper is to introduce the outline and describe the salient features of the “Joint Guidelines for Safe Handling of Cancer Chemotherapy Drugs” (hereinafter, “Guideline”), which were published in July 2015. The purpose of thi

Externí odkaz: https://doaj.org/article/63d8dec7957342a895711e6bec583497

Zobrazit plný text záznamu

Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer

Autor: Hiroyuki Daiko, Kunihiko Itoh, Shohei Ueno, Satoshi Fujii, Daiki Tsuji, Toshikatsu Kawasaki, Hisanaga Nomura, Takashi Kojima, Tomonori Yano, Ken Demachi

Publikováno v: Investigational New Drugs. 40:420-429

Purpose: Docetaxel, cisplatin, and 5-fluorouracil (DCF) have high response rates, but severe neutropenia is frequently observed. The occurrence of neutropenia is associated with high histological response in solid tumors, and it might be associated w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ff9447e2d8aac685a547f5094c4fdd
https://doi.org/10.1007/s10637-021-01199-y

Zobrazit plný text záznamu

Community pharmacists' measurement of health-related quality of life in outpatients taking high-risk drugs

Autor: Satoshi Yuge, Ryota Tsukioka, Katsuaki Miyahara, Kenichi Suzuki, Takenori Ichimura, Hisanori Shimizu, Tomonobu Yoshimura, Hayato Murata, Keisuke Kado, Chiaki Ogawa, Hisanaga Nomura

Publikováno v: Die Pharmazie. 77(6)

Background: Patients who develop severe side-effects when taking high-risk drugs may have a significantly reduced health-related quality of life (QOL); therefore, it is important to identify changes in health-related QOL in these patients. This study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb58c591212db71b0e95ff7ed50d1334
https://pubmed.ncbi.nlm.nih.gov/35751159

Zobrazit plný text záznamu

ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy

Autor: Takashi Kojima, Satoshi Fujii, Hiroyuki Daiko, Hisanaga Nomura, Tomonori Yano, Toshikatsu Kawasaki, Ken Demachi, Nobuo Mochizuki, Daiki Tsuji, Haruki Matsuzawa, Kunihiko Itoh

Publikováno v: Cancer Chemotherapy and Pharmacology. 86:315-324

The combination of docetaxel, cisplatin and 5-fluorouracil (DCF) is a newly developed chemotherapy regimen for esophageal cancer. Severe neutropenia is dose-limiting toxicity of docetaxel and it is well known to be frequently occurred during DCF chem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca1815d69640b28ac39fe4700d040c76
https://doi.org/10.1007/s00280-020-04118-9

Zobrazit plný text záznamu

International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care

Autor: Barbara Yim, Mário L de Lemos, Maggie Patterson, Alexandre Chan, Shaun O'Connor, Mayde Seadi Torriani, Hisanaga Nomura, Milagros Cubilla, Morgan B. Frazer, Jim Siderov, Emma Foreman, Rodrigo Spineli Macedo, Joseph S. Bubalo, Harbans Dhillon, Nirachorn Kuchonthara, Winnie Mwangi, Annemeri Livinalli, Himanshu Patel, Jatinder Harchowal

Publikováno v: Journal of Oncology Pharmacy Practice. 26:3-10

With the development of innovative cancer treatments over recent decades, the cost of cancer care has risen exponentially, limiting patient access to patented originator biotherapeutics in many countries. The introduction of biosimilars to the market

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c325193d6eb01ec5af1f0025c00cf9e9
https://doi.org/10.1177/1078155219893441

Zobrazit plný text záznamu

Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners

Publikováno v: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Introduction The coronavirus of 2019 pandemic has necessitated vast and rapid changes in the way oncology pharmacy services are delivered around the world. Methods/aims An international survey of oncology pharmacists and technicians was conducted via

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c68a071312077ef0ba6fb9b33b5304
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4266

Zobrazit plný text záznamu

Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer

Autor: Yosuke Maki, Hiroyuki Daiko, Takashi Kojima, Masaki Tanaka, Toshikatsu Kawasaki, Nobuo Mochizuki, Ken Hatogai, Shinichiro Saito, Hisanaga Nomura

Publikováno v: Supportive Care in Cancer. 28:1849-1854

The aim of the present study was to evaluate the incidence and explore the risk factors of febrile neutropenia (FN) in patients with esophageal cancer receiving neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in real-world set

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9405ee776b89086a6ecda2dfc97cb4ff
https://doi.org/10.1007/s00520-019-05001-x

Zobrazit plný text záznamu

Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital

Autor: Motoyasu Miyazaki, Osamu Imakyure, Koichi Matsuo, Hisanaga Nomura, Masanobu Uchiyama

Publikováno v: BMC Health Services Research
BMC Health Services Research, Vol 20, Iss 1, Pp 1-7 (2020)

Background The substantial increase in the use of expensive anticancer drugs has been accompanied by an increase in the amount of disposing residual liquid from drug preparations. Many Western countries, including the United States, have implemented

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c342d77b14e2c1d96df03a972a230466
https://doi.org/10.1186/s12913-020-05822-1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání